Charité Universitätsmedizin Berlin | Institute of Allergology (IFA) - Campus Benjamin Franklin logo

Charité Universitätsmedizin Berlin | Institute of Allergology (IFA) - Campus Benjamin Franklin

Research site
Location
Hindenburgdamm 30, Berlin, Berlin, Germany
Contact this site

Team Study-Start-Up & Coordination

Verified by this site

Trials

14 of 15
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis

This is a randomized, double-blind, placebo-controlled, Phase 2/3 study comparing the efficacy and safety of BLU-263 + best supportive care (BSC) wit...

Enrolling
Monoclonal Mast Cell Activation Syndrome
Indolent Systemic Mastocytosis
Drug: BLU-263
Drug: Placebo

This is a multi-part, randomized, double-blind, placebo-controlled Phase 2 clinical study comparing the safety and efficacy of bezuclastinib (CGT9486...

Enrolling
Mastocytosis
Mastocytosis, Systemic
Drug: Bezuclastinib Tablets (Formulation A)
Drug: Placebo Tablets

The purpose of this trial is:to assess the efficacy, pharmacokinetics, and safety of remibrutinib vs. placebo in adolescents from 12 to < 18 years of...

Enrolling
Chronic Spontaneous Urticaria
Drug: placebo
Drug: LOU064 (blinded)

The goal of this trial is to enable the collection of information about long-term safety and clinical activity of STAR-0215 in participants with here...

Invitation-only
Hereditary Angioedema
Drug: STAR-0215

The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in...

Active, not recruiting
Chronic Spontaneous Urticaria
Biological: barzolvolimab
Drug: Matching Placebo

The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in...

Active, not recruiting
Chronic Inducible Urticaria
Biological: barzolvolimab
Drug: Matching Placebo

The goal of this clinical trial is to test the drug STAR-0215 in participants with hereditary angioedema (HAE). One group of participants will get 1...

Enrolling
Hereditary Angioedema
Drug: STAR-0215
Locations recently updated

The purpose of this extension study is to collect long-term efficacy, safety and tolerability data on remibrutinib in a selected group of participant...

Enrolling
Chronic Spontaneous Urticaria
Drug: LOU064 (blinded)
Drug: LOU064 (open label)

The purpose of this study is to investigate the safety, PK / PD, and efficacy of SC CSL312 for prophylactic treatment of pediatric subjects with HAE.

Enrolling
Hereditary Angioedema (HAE)
Biological: CSL312

This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blin...

Enrolling
Chronic Spontaneous Urticaria
Drug: Briquilimab
Other: Placebo

This study evaluates the safety and efficacy of long-term on-demand treatment with orally administered deucrictibant for acute hereditary angioedema...

Enrolling
Hereditary Angioedema - Type 2
Hereditary Angioedema Types I and II
Drug: deucrictibant low dose
Drug: deucrictibant selected dose

This phase 1b trial will evaluate the effects of EP262 in subjects with Chronic Inducible Urticaria (CIndU), including symptomatic dermographism and...

Enrolling
Chronic Inducible Urticaria
Drug: Oral EP262

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects with Chronic Spontaneous Urtica...

Enrolling
Chronic Spontaneous Urticaria
Drug: Oral EP262
Drug: Placebo

This is a multicenter pharmacokinetic (PK) subtrial to investigate the PK profile of KVD900 in adolescent patients 12 to 17 years of age with Heredit...

Enrolling
Hereditary Angioedema
Drug: KVD900 600 mg

Trial conditions

Urticaria (8 trials)
Angioedema (5 trials)
Chronic Urticaria (5 trials)
Hereditary Angioedemas (5 trials)
Chronic Inducible Urtica... (2 trials)
Mastocytosis (2 trials)
Systemic Mastocytosis (2 trials)
Hereditary Angioedema Ty... (1 trial)
Mast Cell Activation Dis... (1 trial)
Mast Cell Activation Syn... (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems